Abstract
Despite the increasing success of antiretroviral therapy (ART), virologic failure of the 3 original classes [triple-class virologic failure, (TCVF)] still develops in a small minority of patients who started therapy in the triple combination ART era. Trends in the incidence and prevalence of TCVF over calendar time have not been fully characterised in recent years.
| Originalsprog | Engelsk |
|---|---|
| Tidsskrift | Journal of acquired immune deficiency syndromes (1999) |
| Vol/bind | 59 |
| Udgave nummer | 3 |
| Sider (fra-til) | 294-9 |
| Antal sider | 6 |
| DOI | |
| Status | Udgivet - 2012 |
Fingeraftryk
Dyk ned i forskningsemnerne om 'Calendar time trends in the incidence and prevalence of triple-class virologic failure in antiretroviral drug-experienced people with HIV in Europe'. Sammen danner de et unikt fingeraftryk.Citationsformater
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS